How PRP Tubes Are Manufactured — Inside an ISO 13485 Production Facility
Mariana RuizShare
Introduction
PRP tubes are medical devices — not commodities. The difference between a tube that produces consistent, sterile, platelet-rich plasma suitable for injection and one that does not lies in the manufacturing process: the controlled environments, validated sterilization cycles, quality management systems, and documentation infrastructure that underpin every unit produced.
For clinic operators and procurement managers evaluating PRP tube suppliers, understanding the manufacturing process provides a framework for assessing supplier quality beyond price comparisons and marketing claims. This article walks through the end-to-end manufacturing chain of a CE-marked PRP tube, from raw material receipt to final batch release, within an ISO 13485-certified production environment.
1. The Manufacturing Chain — Overview
PRP tube manufacturing involves six sequential stages, each governed by documented procedures and quality control checkpoints:
``` Raw Material → Tube Forming → Anticoagulant/Gel Filling → Assembly & Packaging → Sterilization → QC & Batch Release ```
Each stage is conducted within a controlled production environment with environmental monitoring, in-process quality checks, and full batch traceability from raw material lot to finished product unit.
2. Stage-by-Stage Manufacturing Process
Stage 1: Raw Material Receipt & Verification
All incoming materials undergo documented verification against specifications before acceptance into production:
| Material | Specification | Verification |
|---|---|---|
| Medical-grade PET / Glass | Dimensional tolerance, clarity, surface finish, centrifugability | Visual inspection, dimensional measurement, burst/centrifuge testing |
| ACD-A solution | Concentration, pH, sterility, endotoxin limits | Chemical assay, pH measurement, bioburden testing |
| Thixotropic gel | Density (~1.04–1.06 g/cm³), viscosity, inertness | Density measurement, centrifugation performance validation |
| Rubber stopper | Puncture resealability, chemical inertness, vacuum retention | Penetration force, vacuum decay testing |
| Packaging materials | Sterile barrier integrity, seal strength | Seal peel testing, bubble emission testing |
Each raw material lot is assigned a unique identifier that links to every finished tube lot produced from it — this is the foundation of the batch traceability system required by ISO 13485.
Stage 2: Tube Forming & Assembly
For PET tubes: Medical-grade polyethylene terephthalate resin is injection-molded into tube bodies under controlled temperature and pressure conditions. The molding process is validated to produce tubes with:
- Consistent wall thickness for uniform centrifugation performance
- Smooth interior surface to minimize premature platelet activation
- Dimensional precision for correct stopper fit and vacuum integrity
For glass tubes: Medical-grade borosilicate glass tubing is cut, formed, and annealed to produce tubes with consistent internal diameter, length, and wall thickness.
In-process checks: Dimensional sampling, visual inspection for defects, vacuum draw verification.
Stage 3: Anticoagulant & Gel Dispensing
This is the most technically critical stage. Each tube receives:
- A precisely measured volume of anticoagulant (ACD-A or sodium heparin) dispensed into the tube by automated filling equipment
- The thixotropic gel separator, positioned at the bottom of the tube
Fill volume accuracy is critical: under-filled anticoagulant may fail to prevent clotting; over-filled anticoagulant may dilute the platelet fraction. Automated dispensing systems are calibrated and verified at defined intervals throughout each production run.
Environmental controls: Temperature and humidity are maintained within specified ranges to ensure consistent gel viscosity and anticoagulant stability.
In-process checks: Fill volume sampling, gel integrity assessment, anticoagulant concentration verification.
Stage 4: Stopper Placement & Vacuum Draw
The rubber stopper is inserted under partial vacuum conditions, creating the negative pressure inside the tube that enables blood draw. Vacuum draw volume is specified for the tube size — for example, a 10ml PRP tube is designed to draw approximately 10ml of whole blood under standard venous pressure.
In-process checks: Vacuum draw verification per sampling plan, stopper seal integrity testing.
Stage 5: Individual Packaging & Labeling
Each tube is individually packaged in a sterile barrier pouch (typically medical-grade paper/plastic laminate or Tyvek/poly). Packaging is performed in an ISO Class 7 (or higher) cleanroom environment.
Each unit receives:
- A unique lot number for full traceability
- Expiration date based on validated shelf-life testing
- Product identification (tube type, size, anticoagulant)
- CE mark with Notified Body identification number (4 digits)
- Single-use symbol and sterilization indicator
Stage 6: Sterilization
Sterilization is performed by validated methods, typically:
- Ethylene oxide (EtO): Validated to ISO 11135. Appropriate for temperature-sensitive materials. Post-sterilization aeration removes residual EtO to levels below internationally accepted limits.
- Gamma irradiation: Validated to ISO 11137. Alternative method for materials compatible with radiation exposure.
The sterilization process is validated to achieve a Sterility Assurance Level (SAL) of 10⁻⁶ — meaning the probability of a non-sterile unit is less than one in one million.
Sterilization batch records are maintained as part of the device history record for each lot.
3. Quality Control & Batch Release
Before a finished product batch is released for distribution, the following QC activities are completed:
| QC Activity | Method | Acceptance Criterion |
|---|---|---|
| Sterility testing | Membrane filtration or direct inoculation (per pharmacopoeia) | No growth after 14-day incubation |
| Endotoxin testing | LAL (Limulus Amebocyte Lysate) assay | Below specified endotoxin limit |
| Fill volume | Gravimetric sampling | Within validated tolerance |
| Vacuum draw | Water draw volumetric test | Within specification for tube size |
| Gel migration | Centrifugation simulation at specified RPM | Clean layer formation, stable barrier |
| Visual inspection | 100% inspection under controlled lighting | No visible defects |
| Label accuracy | Sampling verification | Lot number, expiration, CE mark present and correct |
A Certificate of Analysis (CoA) is issued for each released batch, summarizing the QC test results. The CoA should be available to customers upon request.
4. ISO 13485: The Framework That Holds It Together
ISO 13485 is the internationally recognized quality management standard specific to medical device manufacturing. It is not a product performance standard — it is a process standard that specifies requirements for a quality management system covering:
- Document control: Every procedure, specification, and record is documented and version-controlled
- Design control: Product design is developed under documented procedures with design inputs, outputs, review, verification, and validation
- Purchasing control: Suppliers are evaluated, approved, and monitored; purchased materials are verified against specifications
- Production control: Manufacturing is conducted under controlled conditions with documented work instructions, environmental monitoring, and in-process inspection
- Traceability: Every finished product unit is traceable to its raw material lots, production date, equipment, and operator
- Corrective and preventive action (CAPA): Non-conformances are investigated, root causes identified, and corrective actions implemented and verified
- Internal audit: Regular internal audits verify that the quality management system is functioning as designed
- Management review: Senior management periodically reviews quality system performance, audit results, customer feedback, and improvement opportunities
ISO 13485 certification is maintained through annual surveillance audits conducted by an independent certification body. The certification is renewed every three years through a full recertification audit.
5. What to Look for When Evaluating a PRP Tube Manufacturer
Use the following checklist when assessing PRP tube suppliers:
| Verification Point | What to Ask For |
|---|---|
| ISO 13485 certificate | Current certificate with scope covering PRP tube manufacturing. Verify the issuing certification body and expiration date |
| CE certificate | CE certificate number and Notified Body 4-digit identification. Verify in the NANDO database |
| Certificate of Analysis (CoA) | Batch-specific CoA showing sterility, endotoxin, fill volume, and visual inspection results |
| Sterilization validation | Evidence that sterilization (EtO or gamma) has been validated to ISO 11135 or ISO 11137 |
| Biocompatibility | ISO 10993 test reports for cytotoxicity, sensitization, and irritation |
| Shelf-life validation | Evidence of real-time and/or accelerated aging studies supporting the labeled expiration date |
| Batch traceability | Demonstration that every unit can be traced from finished product back to raw material lots |
A manufacturer that can provide all of the above documentation on request is operating a mature, audited quality management system. A manufacturer that cannot — or is reluctant to — should be approached with appropriate caution.
Manufacturing depth is exactly what manufacturer-direct buyers should verify: VivaPRP produces tubes and kits in-house under ISO 13485. Review OEM & private-label service for branded programs or start with the tube range.
Frequently Asked Questions
How long does it take to manufacture a batch of PRP tubes?
Production lead time varies with batch size and configuration complexity. A standard production run from raw material receipt to finished product release typically ranges from 2–4 weeks, excluding raw material procurement lead time and sterilization cycle duration.
Are PRP tubes manufactured in a sterile environment?
The final assembly and packaging stages are performed in ISO Class 7 (or higher) cleanroom environments. Sterility of the finished product is achieved through terminal sterilization (EtO or gamma irradiation) after packaging, not through aseptic manufacturing alone.
How is batch traceability maintained?
Every tube carries a unique lot number. This lot number is linked in the manufacturer's records to: raw material lots (PET/glass, anticoagulant, gel, stopper, packaging), production date, equipment used, operators, in-process QC results, sterilization batch, and final QC release data. This traceability chain enables rapid investigation in the event of a quality issue.
Can I visit a PRP tube manufacturing facility?
Many manufacturers — including VivaPRP — offer facility visits or virtual tours for qualified wholesale and OEM partners. A willingness to provide facility access is generally a positive indicator of manufacturing transparency.
What is the difference between EtO and gamma sterilization for PRP tubes?
Both are validated terminal sterilization methods. Ethylene oxide (EtO) is a gas sterilization process suitable for temperature-sensitive materials; it requires a post-sterilization aeration period to remove residual gas. Gamma irradiation uses ionizing radiation and is faster but may affect some polymer materials — tube material selection must be compatible with the chosen sterilization method.
Disclaimer: This article describes general medical device manufacturing practices consistent with ISO 13485 requirements. Specific manufacturing procedures vary by manufacturer and product configuration. Verify all quality documentation directly with the manufacturer before procurement decisions.
VivaPRP manufactures CE-certified PRP tubes under ISO 13485 quality management. For documentation, facility information, or to discuss wholesale and OEM partnerships, contact our team.